Chih-Chia Yu

发表

Searching cell‐secreted proteomes for potential urinary bladder tumor markers

K. Tsui, P. Chang, B. Yung, 2006, Proteomics.

Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo

Yu-Chieh Su, H. Liao, Hsu-Chueh Ho, 2017, Oncotarget.

Association of acute phase protein-haptoglobin, and epithelial-mesenchymal transition in buccal cancer: a preliminary report

Yu-Chieh Su, Shu-Mei Chang, Hsu-Chueh Ho, 2012, Clinical chemistry and laboratory medicine.

Functional regulation and proteomic characterization of human natural killer cells through recombinant human granulocyte‐colony stimulating factor treatment

Shui-Tein Chen, H. Liao, Yu-Jen Chen, 2009 .

Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma.

Yu-Chieh Su, Hsu-Chueh Ho, S. Hung, 2010, Clinica chimica acta; international journal of clinical chemistry.

AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest

Yu-Chieh Su, Szu-Chin Li, H. Liao, 2016, PloS one.

Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells

H. Liao, Guang-Sheng Wang, Yu-Jen Chen, 2008, Anti-cancer drugs.

Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care

S. Hung, Moon-Sing Lee, W. Chiou, 2020, Frontiers in Cardiovascular Medicine.

RAD001 enhances the radiosensitivity of SCC4 oral cancer cells by inducing cell cycle arrest at the G2/M checkpoint.

H. Liao, Hsu-Chueh Ho, S. Hung, 2014, Anticancer Research.

mTORC1/2 Inhibitor Served as a More Ideal Agent Against the Growth of Mouse Lymphocytic Leukemia Both In Vitro and In Vivo

H. Liao, S. Hung, Tzong-Shyuan Tai, 2019, AntiCancer Research.